Market Overview:
The global coronary artery bypass grafts (CABG) market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The market growth is attributed to the increasing prevalence of coronary artery diseases, technological advancements in CABG procedures, and rising geriatric population. Based on type, the global coronary artery bypass grafts (CABG) market is segmented into saphenous vein grafts, internal thoracic artery grafts, and other types. The saphenous vein grafts segment accounted for the largest share of the global CABG market in 2017 and is projected to grow at a higher rate during the forecast period. This can be attributed to factors such as easy availability of veins for harvesting and low cost as compared to other types of graft materials. Based on application, the global coronary artery bypass grafts (CABG) market is divided into traditional CABG procedures and nontraditional CABG procedures.
Product Definition:
A coronary artery bypass graft (CABG) is a surgical procedure that uses a piece of vein, usually from the leg, to create a new path for blood flow around a blocked or narrowed coronary artery. This allows more blood and oxygen to reach the heart muscle.
Saphenous Vein Grafts:
Saphenous vein grafts are used to bypass the blocked or narrowing coronary artery. The growth of the market is dependent on various factors such as rising prevalence of cardiovascular diseases, increasing demand for heart valve replacement surgeries and technological advancements in cardiac surgery. According to WHO, each year around 17 million people die from CVDs which accounts for 31% of global deaths.
Internal Thoracic Artery Grafts:
An internal thoracic artery graft (ITA) is a surgical device used to bypass an obstructed coronary artery. The ITA works by taking blood from the contralateral femoral artery and transferring it to the coronary arteries via a tunneled approach. It is one of the most commonly used vessels for CABG surgery, especially in patients suffering from high-flow/high-pressure arterial disease or when other vessels cannot be utilized.
Application Insights:
By application, the global coronary artery bypass grafts (CABG) market is segmented into traditional CABG, nontraditional CABG and others. The traditional type of coronary artery bypass grafts accounted for the largest share in 2017 owing to its higher rate of adoption and availability in most countries.
Nontraditional applications are expected to grow at a faster pace over the forecast period due to increasing usage rates coupled with technological advancements that have made these procedures less invasive than before. For instance, saphenous vein Grafting (SVG) has gained popularity as an alternative procedure for patients who cannot undergo a conventional cardiac surgery or those who refuse because they are too obese for open heart surgery.
Regional Analysis:
North America dominated the global coronary artery bypass grafts market in 2016 with a revenue share of over 35%. The growth can be attributed to various factors such as increasing prevalence of CVD, rising adoption of minimally invasive surgeries, and high per capita healthcare expenditure. Moreover, favorable reimbursement policies for CABG procedures are also expected to drive the regional market during the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to improving healthcare infrastructure and growing patient awareness regarding available treatment options for Coronary Artery Disease (CAD). In addition, booming medical tourism industry in emerging economies like India & China is also expected boost demand for CABG surgeries in this region.
Growth Factors:
- Increasing incidence of coronary artery diseases (CAD) due to changing lifestyle and dietary habits
- Rising geriatric population susceptible to CAD
- Technological advancements in CABG procedures that improve outcomes
- Growing demand for minimally invasive surgeries for CABG procedures
- increasing healthcare expenditure by governments and private players to support treatment of CAD
Scope Of The Report
Report Attributes
Report Details
Report Title
Coronary Artery Bypass Grafts (CABG) Market Research Report
By Type
Saphenous Vein Grafts, Internal Thoracic Artery Grafts, Other
By Application
Traditional CABG, Nontraditional CABG,
By Companies
Medtronic, Getinge Group, LivaNova, Terumo, Boston Scientific, Stryker, Edwards Lifesciences, Genesee Biomedical, Karl Storz GmbH,
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Coronary Artery Bypass Grafts (CABG) Market Report Segments:
The global Coronary Artery Bypass Grafts (CABG) market is segmented on the basis of:
Types
Saphenous Vein Grafts, Internal Thoracic Artery Grafts, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Traditional CABG, Nontraditional CABG,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Getinge Group
- LivaNova
- Terumo
- Boston Scientific
- Stryker
- Edwards Lifesciences
- Genesee Biomedical
- Karl Storz GmbH
Highlights of The Coronary Artery Bypass Grafts (CABG) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Saphenous Vein Grafts
- Internal Thoracic Artery Grafts
- Other
- By Application:
- Traditional CABG
- Nontraditional CABG
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Coronary Artery Bypass Grafts (CABG) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A coronary artery bypass graft (CABG) is a surgical procedure to restore blood flow to an area of the heart that has been blocked by atherosclerosis or another type of heart disease. The surgeon makes a small incision in the chest and uses a catheter to insert a tube into one of the patient's coronary arteries. The surgeon then cuts off part of the artery, and using stents, attaches it directly to another part of the artery near where it enters the heart. This allows blood flow through both arteries again.
Some of the key players operating in the coronary artery bypass grafts (cabg) market are Medtronic, Getinge Group, LivaNova, Terumo, Boston Scientific, Stryker, Edwards Lifesciences, Genesee Biomedical, Karl Storz GmbH.
The coronary artery bypass grafts (cabg) market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Coronary Artery Bypass Grafts (CABG) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Coronary Artery Bypass Grafts (CABG) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Coronary Artery Bypass Grafts (CABG) Market - Supply Chain
4.5. Global Coronary Artery Bypass Grafts (CABG) Market Forecast
4.5.1. Coronary Artery Bypass Grafts (CABG) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Coronary Artery Bypass Grafts (CABG) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Coronary Artery Bypass Grafts (CABG) Market Absolute $ Opportunity
5. Global Coronary Artery Bypass Grafts (CABG) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Coronary Artery Bypass Grafts (CABG) Market Size and Volume Forecast by Type
5.3.1. Saphenous Vein Grafts
5.3.2. Internal Thoracic Artery Grafts
5.3.3. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Coronary Artery Bypass Grafts (CABG) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Coronary Artery Bypass Grafts (CABG) Market Size and Volume Forecast by Application
6.3.1. Traditional CABG
6.3.2. Nontraditional CABG
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Coronary Artery Bypass Grafts (CABG) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Coronary Artery Bypass Grafts (CABG) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Coronary Artery Bypass Grafts (CABG) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Coronary Artery Bypass Grafts (CABG) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Coronary Artery Bypass Grafts (CABG) Demand Share Forecast, 2019-2026
9. North America Coronary Artery Bypass Grafts (CABG) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Coronary Artery Bypass Grafts (CABG) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Coronary Artery Bypass Grafts (CABG) Market Size and Volume Forecast by Application
9.4.1. Traditional CABG
9.4.2. Nontraditional CABG
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Coronary Artery Bypass Grafts (CABG) Market Size and Volume Forecast by Type
9.7.1. Saphenous Vein Grafts
9.7.2. Internal Thoracic Artery Grafts
9.7.3. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Coronary Artery Bypass Grafts (CABG) Demand Share Forecast, 2019-2026
10. Latin America Coronary Artery Bypass Grafts (CABG) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Coronary Artery Bypass Grafts (CABG) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Coronary Artery Bypass Grafts (CABG) Market Size and Volume Forecast by Application
10.4.1. Traditional CABG
10.4.2. Nontraditional CABG
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Coronary Artery Bypass Grafts (CABG) Market Size and Volume Forecast by Type
10.7.1. Saphenous Vein Grafts
10.7.2. Internal Thoracic Artery Grafts
10.7.3. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Coronary Artery Bypass Grafts (CABG) Demand Share Forecast, 2019-2026
11. Europe Coronary Artery Bypass Grafts (CABG) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Coronary Artery Bypass Grafts (CABG) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Coronary Artery Bypass Grafts (CABG) Market Size and Volume Forecast by Application
11.4.1. Traditional CABG
11.4.2. Nontraditional CABG
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Coronary Artery Bypass Grafts (CABG) Market Size and Volume Forecast by Type
11.7.1. Saphenous Vein Grafts
117.2. Internal Thoracic Artery Grafts
11.7.3. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Coronary Artery Bypass Grafts (CABG) Demand Share, 2019-2026
12. Asia Pacific Coronary Artery Bypass Grafts (CABG) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Coronary Artery Bypass Grafts (CABG) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Coronary Artery Bypass Grafts (CABG) Market Size and Volume Forecast by Application
12.4.1. Traditional CABG
12.4.2. Nontraditional CABG
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Coronary Artery Bypass Grafts (CABG) Market Size and Volume Forecast by Type
12.7.1. Saphenous Vein Grafts
12.7.2. Internal Thoracic Artery Grafts
12.7.3. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Coronary Artery Bypass Grafts (CABG) Demand Share, 2019-2026
13. Middle East & Africa Coronary Artery Bypass Grafts (CABG) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Coronary Artery Bypass Grafts (CABG) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Coronary Artery Bypass Grafts (CABG) Market Size and Volume Forecast by Application
13.4.1. Traditional CABG
13.4.2. Nontraditional CABG
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Coronary Artery Bypass Grafts (CABG) Market Size and Volume Forecast by Type
13.7.1. Saphenous Vein Grafts
13.7.2. Internal Thoracic Artery Grafts
13.7.3. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Coronary Artery Bypass Grafts (CABG) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Coronary Artery Bypass Grafts (CABG) Market: Market Share Analysis
14.2. Coronary Artery Bypass Grafts (CABG) Distributors and Customers
14.3. Coronary Artery Bypass Grafts (CABG) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medtronic
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Getinge Group
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. LivaNova
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Terumo
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Boston Scientific
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Stryker
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Edwards Lifesciences
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Genesee Biomedical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Karl Storz GmbH
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10.
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook